2nd Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

Firm
Client
Income
—
Expenses
$185,959
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

BARDA (Biodefense Advanced Research and Development Authority) Funding in FY2009 Supplemental Appropriations Act (PL 111-32) as well as in American Recovery and Reinvestment Act of 2009 (PL 111-5) to fund vaccines and therapeutics against CBRN threats. Education of Congressional Members and Staff on biological-chemical terrorist threats to the U.S. Funding for BARDA/HHS in the Presidents FY2010 Budget.

LobbyistCovered position, as disclosed
MARK EDWARD COOKE Sr. Director, Government Affairs

Contacted: Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.